ArticleWorld journal of gastroenterology2025
Identification of key factors and explainability analysis for surgical decision-making in hepatic alveolar echinococcosis assisted by machine learning.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Alveolar Echinococcosis in the Early 2020s: A Systematic Review.Pathogens (Basel, Switzerland) · 2026Pooled it
- Topological feature-driven TabPFN model for prediction of enlarged hemorrhage and edema after tumor resection in meningiomas.Frontiers in medicine · 2026Article
- Development and Validation of a Predictive Model for Surgical Site Infection in Open Hand Injuries.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEchinococcosis, caused by Echinococcus parasites, includes alveolar echinococcosis (AE), the most lethal form, primarily affecting the liver with a 90% mortality rate without prompt treatment. While radical surgery combined with antiparasitic therapy is ideal, many patients present late, missing hepatectomy opportunities.
aimTo determine the key preoperative factors influencing surgical decision-making in hepatic AE (HAE) using machine learning.
methodsThis was a retrospective cohort study at the First Affiliated Hospital of Xinjiang Medical University (July 2010 to August 2024). There were 710 HAE patients (545 hepatectomy and 165 ELRA) with complete clinical data. Data included demographics, laboratory indicators, imaging, and pathology. Feature selection was performed using recursive feature elimination, minimum redundancy maximum relevance, and least absolute shrinkage and selection operator regression, with the intersection of these methods yielding 10 critical features. Eleven machine-learning algorithms were compared, with eXtreme Gradient Boosting (XGBoost) optimized using Bayesian optimization. Model interpretability was assessed using SHAP analysis.
resultsThe XGBoost model achieved an area under the curve of 0.935 in the training set and 0.734 in the validation set. The optimal threshold (0.28) yielded sensitivity of 93.6% and specificity of 90.9%. SHAP analysis identified type of vascular invasion as the most important feature, followed by platelet count and prothrombin time. Lesions invading the hepatic vein, inferior vena cava, or multiple vessels significantly increased the likelihood of ELRA. Calibration curves showed good agreement between predicted and observed probabilities (0.2-0.7 range). The model demonstrated high net clinical benefit in Decision Curve Analysis, with accuracy of 0.837, recall of 0.745, and F1 score of 0.788.
conclusionVascular invasion is the dominant factor influencing the choice of surgical approach in HAE. Machine-learning models, particularly XGBoost, can provide transparent and data-driven support for personalized decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.